Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera

Xuping Xie; Yang Liu; Jianying Liu; Xianwen Zhang; Jing Zou; Camila R. Fontes-Garfias; Hongjie Xia; Kena A. Swanson; Mark Cutler; David Cooper; Vineet D. Menachery; Scott C. Weaver; Philip R. Dormitzer; Pei‐Yong Shi

doi:10.1038/s41591-021-01270-4

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera

Xuping Xie(The University of Texas Medical Branch at Galveston), Yang Liu(The University of Texas Medical Branch at Galveston), Jianying Liu(The University of Texas Medical Branch at Galveston), Xianwen Zhang(The University of Texas Medical Branch at Galveston), Jing Zou(The University of Texas Medical Branch at Galveston), Camila R. Fontes-Garfias(The University of Texas Medical Branch at Galveston), Hongjie Xia(The University of Texas Medical Branch at Galveston), Kena A. Swanson(Pfizer (United States)), Mark Cutler(Pfizer (United States)), David Cooper(Pfizer (United States)), Vineet D. Menachery(The University of Texas Medical Branch at Galveston), Scott C. Weaver(The University of Texas Medical Branch at Galveston), Philip R. Dormitzer(Pfizer (United States)), Pei‐Yong Shi(The University of Texas Medical Branch at Galveston)

Nature Medicine

February 8, 2021

10.1038/s41591-021-01270-4

Cited by 674Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis